Cellcolabs AB is conducting a long-term follow-up study in Sweden in which individuals who have previously been treated with mesenchymal stem cells may participate. The study includes blood sampling for the analysis of biomarkers related to inflammation, immunological parameters, and aging. Participants will also take part in physician-led interviews regarding their health status and complete simple electronic questionnaires to report on their health and quality of life. No treatment is provided as part of the study, and participation is free of charge.
Want to explore mesenchymal stem cells in more detail?
